Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dean Kirkel
Observed names:
D. M. Kirkel,
Dean M. Kirkel
Observed institutions:
WellStar Health System,
Children's National,
George Washington University
OpenAlex ID:
A5025068936
Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial
2019
·
Paul G Richardson
, Albert Oriol
, et al.
·
The Lancet Oncology
·
384
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial
2019
·
Maria-Victoria Mateos
, Hilary Blacklock
, et al.
·
The Lancet Haematology
·
258
PDF
Acalabrutinib Plus Bendamustine-Rituximab in Untreated Mantle Cell Lymphoma
2025
·
Michael Wang
, Michael Wang
, et al.
·
Journal of Clinical Oncology
·
66
Asymptomatic factor VII deficiency: gene analysis and structure–function relationships
2009
·
Dean Kirkel
, Ta-Wei Lin
, et al.
·
Blood Coagulation & Fibrinolysis
·
16
Immune Thrombocytopenic Purpura following Administration of mRNA-Based SARS-CoV-2 and MMR Vaccinations: A Cautionary Tale
2021
·
Whitney Thomas
, Adam Albano
, et al.
·
Case Reports in Infectious Diseases
·
3
PDF
O-MAX Chemotherapy: High Activity in Metastatic Esophagogastric Adenocarcinoma and Possible Relation to Subclinical Hemolysis
2014
·
James Ahlgren
, Nihar Patel
, et al.
·
Oncology
·
2
Multiple Bony Amyloidomas as an Initial Presentation of Myeloma
2009
·
Dean M. Kirkel
, Edina Paal
, et al.
·
Clinical Lymphoma & Myeloma
·
2
Acknowledgement to the Reviewers
2014
·
James Ahlgren
, Nihar Patel
, et al.
·
Oncology
PDF
Contents Vol. 87, 2014
2014
·
James Ahlgren
, Nihar Patel
, et al.
·
Oncology
PDF
Subclinical C-HUS and complete remission in metastatic gastric cancer treated with C-MAX.
2010
·
J. D. Ahlgren
, S. J. Simmens
, et al.
·
Journal of Clinical Oncology
Combined intra-arterial cisplatin, intravenous chemotherapy, and chemoradiotherapy is an effective program for treating advanced SCC of the head and neck: An analysis of 23 patients with a median follow-up of 6.1 years
2007
·
T. P. O'Connor
, R. R. Batra
, et al.
·
Journal of Clinical Oncology
Show more works
View as search
Works count:
11
Citation count:
731
H-index:
4
I10-index:
4
Year
Topic
Type